Free Trial

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

NovaBay Pharmaceuticals logo
$0.58 -0.03 (-4.26%)
As of 06/30/2025 04:00 PM Eastern

Recent NovaBay Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/04/2025
11:46 AM
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D
04/15/2025
11:40 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:46 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:50 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:11 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:18 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:22 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:30 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:30 PM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:33 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEF 14A
03/11/2025
3:35 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:07 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:08 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
02/06/2025
5:30 PM
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:58 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:58 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:12 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:13 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:27 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:06 PM
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/10/2025
6:03 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
6:00 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:12 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
12/09/2024
6:05 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/26/2024
3:08 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/22/2024
3:27 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:10 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:15 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/12/2024
3:52 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/08/2024
4:31 PM
Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
3:46 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:15 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:19 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
10/16/2024
3:27 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:19 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFM14A
09/25/2024
4:17 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form PREM14A
09/20/2024
7:08 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:08 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
07/29/2024
3:25 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
6:18 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 424B4
07/26/2024
4:19 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form POS EX
Trump Makes Major Crypto Announcement (Ad)

Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.

Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now!
07/25/2024
11:15 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form EFFECT
07/24/2024
7:49 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
07/12/2024
5:21 PM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
07/11/2024
7:50 AM
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form FWP
07/11/2024
7:45 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:05 PM
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form FWP
07/10/2024
8:30 AM
NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:NBY) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners